The development and therapeutic potential of protein kinase inhibitors
β Scribed by Philip Cohen
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 820 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1367-5931
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Pharmaceutical approaches to slow the progression of Alzheimer's disease (AD) have focused primarily on reducing production or increasing clearance of amyloid Ξ² peptide (AΞ²). Recent clinical trial results question the efficacy of targeting AΞ² for treatment of mild to moderate AD, highli
## Abstract The migration of aberrant inflammatory cells into the central nervous system plays an important role in the pathogenesis of demyelinating diseases potentially through the Rho/Rhoβkinase (Rock) pathway, but direct evidence from human and animal models remains inadequate. Here we further
Protein prenylation, adding either the 15-carbon isoprenoid farnesyl or the 20-carbon isoprenoid geranylgeranyl to cysteine residuek) at or near the C-termini of proteins, is a recently identified post-translational modification that localizes some proteins to a membrane compartment. One of the most
## Abstract Protein kinase C (PKC) isozymes are important signal transducers in a number of cellular responses that makes PKC inhibition a topical target for drug discovery. In this study, a set of natural compounds and their derivatives (43 in total) were screened to establish their potential inhi